17 Capital Partners »

Regeneron Pharmaceuticals shares owned by 17 Capital Partners

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by 17 Capital Partners from 13F filings

Historical chart of 17 Capital Partners investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by 17 Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by 17 Capital Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $335k 537 623.54

More positions owned by 17 Capital Partners

Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 0-3 Mth Treasury (SGOV)
Ishares Tr S&p 500 Grwt Etf (IVW)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Advanced Micro Devices (AMD)
Apple (AAPL)
Parker-Hannifin Corporation (PH)
Ishares Tr Core S&p Us Vlu (IUSV)
Ishares Tr S&p 500 Val Etf (IVE)
NVIDIA Corporation (NVDA)
Blackrock Etf Trust Isha Pr Mone Etf (PMMF)
Corteva (CTVA)
First Tr Exchange Traded Risng Divd Achiv (RDVY)

View all positions for 17 Capital Partners

Top funds holding Regeneron Pharmaceuticals

BlackRock
Vanguard Capital Management
Dodge & Cox
State Street Corporation
Invesco
Jpmorgan Chase & Co
Vanguard Portfolio Management
Franklin Resources
Geode Capital Management
T. Rowe Price Associates
Nuveen
Loomis, Sayles and
Capital World Investors
Goldman Sachs Group
Morgan Stanley

View all funds holding Regeneron Pharmaceuticals